Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Colorectal Neoplasms 59Pancreatic Neoplasms 33Colonic Neoplasms 31Rectal Neoplasms 30Stomach Neoplasms 22Neoplasm Metastasis 19Carcinoma, Non-Small-Cell Lung 19Neoplasms 16Unspecified Adult Solid Tumor, Protocol Specific 15Esophageal Neoplasms 12Ovarian Neoplasms 8Gallbladder Neoplasms 7Appendiceal Neoplasms 7Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Lung Neoplasms 6Carcinoma, Renal Cell 6Breast Neoplasms 6Bile Duct Neoplasms 6Peritoneal Neoplasms 5Liver Neoplasms 5Gastrointestinal Neoplasms 5Carcinoma, Hepatocellular 5Adenocarcinoma 5Triple Negative Breast Neoplasms 4Recurrence 4Fallopian Tube Neoplasms 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Pancreatic Ductal 4Squamous Cell Carcinoma of Head and Neck 3

Interventions

pembrolizumab 10Docetaxel 8senaparib 7Injections 7Capecitabine 7Paclitaxel 6Cisplatin 6Irinotecan 5Fluorouracil 5Leucovorin 4Cyclophosphamide 4Bevacizumab 4tislelizumab 3pertuzumab 3fludarabine 3atezolizumab 3Rifampin 3Oxaliplatin 3Itraconazole 3Gemcitabine 3ontuxizumab 2navoximod 2fluzoparib 2durvalumab 2Trastuzumab 2Nivolumab 2Midazolam 2Hydroxychloroquine 2Carboplatin 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumor × Oxaliplatin × Clear all
NCT06576037 2026-04-16

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

M.D. Anderson Cancer Center

Phase 1 Recruiting
128 enrolled
Other solid neoplasm

Solid Tumor

NCT04802980 2021-07-28

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Huabo Biopharm Co., Ltd.

Phase 1 Unknown
72 enrolled
Other solid neoplasm

Solid Tumor

NCT02715531 2021-07-09

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

Hoffmann-La Roche

Phase 1 Completed
243 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡